NASDAQ •
Healthcare •
Biotechnology •
Quote as of 05/29/2026
Company Profile
IndustryBiotechnology
SectorHealthcare
ExchangeNASDAQ
Market Capitalization5,044.69 mln
Float165 mln
Earnings Date08/18/2026
Piotroski F-Score
3
/ 9
Below average
Beneish M-Score
-2.53
Likely reliable
1-Year Forecast
55.39
Transformational upside
Relative Strength
17
/ 100
Significantly lagging
Debt / Equity
0.40
Low leverage
ROE
-24.85
Deeply negative
Business Description
Legend Biotech is a New Jersey-based company focused on developing advanced cell-based treatments for cancer patients across the United States, China, and Europe. Its most prominent product, cilta-cel, is an approved therapy for multiple myeloma that works by reprogramming a patient's own immune cells to attack cancer. The company is also building a broader pipeline of treatments aimed at several other cancer types, while working alongside partners Janssen Biotech and Novartis to expand the reach and development of its therapies.
